Efficiency and safety increases after the implementation of a multi-institutional automated plan check tool at our institution

被引:9
|
作者
Berry, Sean L. [1 ]
Zhou, Ying [1 ]
Pham, Hai [1 ]
Elguindi, Sharif [1 ]
Mechalakos, James G. [1 ]
Hunt, Margie [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
来源
关键词
automation; plan checking; quality and safety; treatment planning;
D O I
10.1002/acm2.12845
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The plan check tool (PCT) is the result of a multi-institutional collaboration to jointly develop a flexible automated plan checking framework designed with the versatility to be shared across collaborating facilities while supporting the individual differences between practices. We analyze the effect that PCT has had on the efficiency and effectiveness of initial chart checks at our institution. Methods and Materials Data on errors identified during initial chart checks were acquired during two time periods: before the introduction of PCT in the clinic (6/24/2015 to 7/31/2015, 187 checks) and post-clinical release (4/14/2016 to 5/2/2016, 186 checks). During each time period, human plan checkers were asked to record all issues that they either manually detected or that were detected by PCT as well as the amount of time, less breaks, or interruptions, it took to check each plan. Results After the clinical release of PCT, there was a statistically significant decrease in the number of issues recorded by the human plan checkers both related to checks explicitly performed by PCT (13 vs 50, P < 0.001) and in issues identified overall (127 vs 200, P < 0.001). The mean and medium time for a plan check decreased by 20%. Conclusions The use of a multi-institutional, configurable, automated plan checking tool has resulted in both substantial gains in efficiency and moving error detection to earlier points in the planning process, decreasing their likelihood that they reach the patient. The sizeable startup effort needed to create this tool from scratch was mitigated by the sharing, and subsequent co-development, of software code from a peer institution.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 34 条
  • [21] Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study
    Di Lena, Elise
    Wong, Stephanie M.
    Iny, Ericka
    Mashal, Sarah
    Basik, Mark
    Boileau, Jean-Francois
    Martel, Karyne
    Bassel, Miranda Addie
    Meterissian, Sarkis
    Prakash, Ipshita
    EJSO, 2024, 50 (06):
  • [22] Development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (SEARCHER): A multi-institutional observational study
    Chen, Zi-Xiang
    Schwartz, Myron
    Gu, Li-Hui
    Liang, Lei
    Wang, Ping
    Cescon, Matteo
    Li, Ju-Dong
    Liang, Ying-Jian
    Pu, Jia-Le
    Zhou, Ya-Hao
    Wang, Hong
    Gu, Wei-Min
    Chen, Ting-Hao
    Chen, Zhi-Yu
    Wang, Ming-Da
    Li, Chao
    Zhang, Cheng-Wu
    Pawlik, Timothy M.
    Lau, Wan Yee
    Shen, Feng
    Liu, Fu-Bao
    Yang, Tian
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 106
  • [23] Development of a Support Vector Machine-Based Tool for Survival Prediction after Stereotactic Body Radiotherapy for Liver Metastases Using Multi-Institutional Data
    Nam, K.
    Arsenault, T.
    Baydoun, A.
    Amini, A.
    Saieed, G.
    Abou Zeidane, R.
    Bhat, S. S.
    Bailey, L.
    Sachdeva, R.
    Chow, R.
    Chu, W.
    Liu, H.
    Chung, H. T.
    Schellenberg, D.
    Swaminath, A.
    Lock, M. I.
    Podder, T. K.
    Biswas, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E122 - E122
  • [24] Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study
    Osarogiagbon, Raymond U.
    Smeltzer, Matthew P.
    Faris, Nicholas R.
    Ray, Meredith A.
    Fehnel, Carrie
    Ojeabulu, Phillip
    Akinbobola, Olawale
    Meadows-Taylor, Meghan
    McHugh, Laura M.
    Halal, Ahmed M.
    Levy, Paul
    Sachdev, Vishal
    Talton, David
    Wiggins, Lynn
    Shu, Xiao-Ou
    Shyr, Yu
    Robbins, Edward T.
    Klesges, Lisa M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : 630 - 642
  • [25] CAN MULTIPARAMETRIC MRI IMPROVE OUR ABILITY TO PREDICT EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN CONTEMPORARY PATIENTS? RESULTS FROM A MULTI-INSTITUTIONAL ANALYSIS
    Gandaglia, Giorgio
    Ploussard, Guillaume
    Valerio, Massimo
    Mattei, Agostino
    Marra, Giancarlo
    Beauval, Jean-Baptiste
    Malavaud, Bernard
    Roumiguie, Mathieu
    Marquis, Alessandro
    Afferi, Luca
    Moschini, Marco
    Rakauskas, Arnas
    Fossati, Nicola
    Barletta, Francesco
    Cannoletta, Donato
    Zito, Elio
    Camisassa, Enrico
    Van den Bergh, Roderick
    De Cobelli, Francesco
    Fiori, Cristian
    Porpiglia, Francesco
    Gontero, Paolo
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2020, 203 : E948 - E949
  • [26] Drain Placement After Uncomplicated Hepatic Resection Increases Severe Postoperative Complication Rate A Japanese Multi-institutional Randomized Controlled Trial (ND-trial)
    Arita, Junichi
    Sakamaki, Kentaro
    Saiura, Akio
    Konishi, Masaru
    Sakamoto, Yoshihiro
    Hashimoto, Masaji
    Sano, Tsuyoshi
    Uesaka, Katsuhiko
    Kokudo, Norihiro
    Yamanaka, Takeharu
    Shimada, Kazuaki
    ANNALS OF SURGERY, 2021, 273 (02) : 224 - 231
  • [27] Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinumbased chemotherapy: multi-institutional retrospective analysis
    Peng, Pei-Jian
    Cheng, Hua
    Ou, Xue-Qing
    Zeng, Lin-Juan
    Wu, Xuan
    Liu, Yu-Meng
    Lin, Zhong
    Tang, Yan-Na
    Wang, Si-Yang
    Zhang, Hong-Yu
    Chen, Zhi-Bin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1083 - 1087
  • [28] A commentary on ′development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study′
    Huo, Teh-Ia
    Ho, Shu-Yein
    Liao, Jia-, I
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (02) : 204 - 205
  • [29] Routine, prospective DPYD genotyping guided dose-individualisation for patients receiving fluoropyrimidines: Implementation, prevalence and patient safety outcomes from a multi-institutional clinical trial
    Nalder, Mark
    Kulasegaran, Tivya
    Lundie, Ben
    Woods, Rick
    Eastgate, Melissa A.
    Wyld, David
    Burge, Matthew E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] In Situ Simulation as a Quality Improvement Tool to Identify and Mitigate Latent Safety Threats for Emergency Department SARS-CoV-2 Airway Management: A Multi-Institutional Initiative
    Yang, Christina J.
    Saggar, Vinay
    Seneviratne, Namal
    Janzen, Alex
    Ahmed, Oark
    Singh, Maninder
    Restivo, Andrew
    Yoon, Andrew
    Bajaj, Komal
    Ahmed, Sadia T.
    Moseley, Mary
    Moss, Hillary
    Jafri, Farrukh N.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2023, 49 (6-7): : 297 - 305